| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AC55649 | CTRPv2 | pan-cancer | AAC | 0.24 | 2e-10 |
| mRNA | Teniposide | CTRPv2 | pan-cancer | AAC | 0.19 | 2e-06 |
| mRNA | prima-1 | CTRPv2 | pan-cancer | AAC | 0.15 | 4e-06 |
| mRNA | neratinib | CTRPv2 | pan-cancer | AAC | 0.16 | 4e-06 |
| mRNA | UNC0321 | CTRPv2 | pan-cancer | AAC | 0.16 | 1e-05 |
| mRNA | BRD-K27188169:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.23 | 1e-05 |
| mRNA | QW-BI-011 | CTRPv2 | pan-cancer | AAC | 0.29 | 5e-05 |
| mRNA | Compound 7d-cis | CTRPv2 | pan-cancer | AAC | 0.15 | 6e-05 |
| mRNA | lapatinib | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0002 |
| mRNA | MI-1 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.0002 |